名稱 | PD1/41BB Dual Effector Reporter Cell |
型號(hào) | CBP74172 |
報(bào)價(jià) | ![]() |
特點(diǎn) | PD1/41BB Dual Effector Reporter Cell |
產(chǎn)品搜索
相關(guān)文章
- 科學(xué)家發(fā)現(xiàn)10個(gè)新的智力障礙易感基因
- HPV分子診斷標(biāo)準(zhǔn)品擴(kuò)容:精準(zhǔn)檢測,實(shí)力升級
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
- 【產(chǎn)品推介】VEGFR-2(KDR)小分子抑制劑細(xì)胞篩選模型
- 治療疼痛的潛力靶點(diǎn)——NGF
- ATCC細(xì)胞株所用培養(yǎng)基有何要求?
- IL-11藥物細(xì)胞模型介紹
- 腸道守護(hù)者--GLP2R
- 細(xì)胞株培養(yǎng)對于培養(yǎng)液的要求及相關(guān)常識(shí)說明
- GLP-1受體激動(dòng)劑細(xì)胞篩選模型
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74172PD1/41BB Dual Effector Reporter Cell

- 詳細(xì)內(nèi)容
CBP74172 | |
I. Background | |
The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated T-cells, to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. The PD-1 ligands are found on most cancers, and PD-1:PD-L1/2 interaction inhibits T cell activity and allows cancer cells to escape immune surveillance. diabetes. Human CD137 (4-1BB; TNFRS9) is an inducible costimulatory molecule that activates T cells. CD137-CD137L mediated signaling has been shown to be important for proliferation, effector functions and survival of T cells. CD137 is also expressed in NK and NKT cells. Antibodies targeting CD137 activation in immune cells have demonstrated potent anti-tumor effects in cancer patients. | |
II. Introduction | |
Expressed gene: | PD1、41BB |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin+800ug/ml hygromycin+10ug/ml blasticidin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Functional(Report Gene) Assay |
III. Representative Data | |
Figure 1. Dose Response of Blocking Antibodies in PD-1/41BB Dual Effector Reporter Cells (C64) With PD-L1 aAPC Cells. | |